Elevatus Welath Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Elevatus Welath Management's LLY Position: Q3 2026 in Review
Elevatus Welath Management increased its Eli Lilly (LLY) stake by 8.9% in Q3 2026, buying an estimated $96.8K and bringing the position to 999 shares worth $1.16M. The position accounts for 0.28% of the portfolio, ranked #70.
Elevatus Welath Management first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. The position peaked at $8.52M in Q1 2024. 1,879 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Elevatus Welath Management held 999 shares of Eli Lilly worth $1.16M as of Q3 2026.
- Elevatus Welath Management bought 82 Eli Lilly shares in Q3 2026, an estimated $96.8K.
- Eli Lilly made up 0.28% of Elevatus Welath Management's portfolio in Q3 2026, its #70 holding.
- Elevatus Welath Management first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
- Elevatus Welath Management's Eli Lilly position peaked at $8.52M in Q1 2024.
- 1,879 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Elevatus Welath Management's 13F filing for Q3 2026, filed 19 Oct 2026.